Dioscin alleviates hashimoto’s thyroiditis by regulating the SUMOylation of IRF4 to promote CD4+CD25+Foxp3+ treg cell differentiation
Dioscin has been used as a treatment for Hashimoto’s thyroiditis (HT) in China. However, the molecular mechanisms governing the modes of action of dioscin have not been elucidated. In this study, flow cytometry and Western blotting were used to identify the proportions of CD4+CD25+ regulatory T (Tre...
Gardado en:
| Principais autores: | , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Taylor & Francis Group
2021-01-01
|
| Series: | Autoimmunity |
| Assuntos: | |
| Acceso en liña: | http://dx.doi.org/10.1080/08916934.2020.1855428 |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|